BioSpace News Archive

Internationally Known Eye Cancer Researcher and Clinician Joins Newest NCI-Designated Cancer Center and Nation’s Top-Ranked Eye Hospital

The Confucius Institute U.S. Center announced today a program to offer translation services and language resources free of charge to medical facilities across the United State

HOUSTON , Feb. 14, 2020 /PRNewswire/ -- In response to the global health emergency caused by the spread of the coronavirus (COVID-19), the Health Law & Policy Institute at the University of Houston Law Center will present a webinar Feb. 19 with health and legal experts providing updates on the outbreak and preparations for its potential threat to the United States .

RB’s accumulated donation exceeds RMB 55 million

Venus Concept Inc. (“Venus Concept” or the “Company”) (NASDAQ: VERO), a global medical aesthetic technology leader, today announced that it has received CE Mark approval to market Venus Bliss for non-invasive lipolysis of the abdomen and flanks, skin tightening, circumferential reduction and cellulite reduction and a medical device license issued by Health Canada to market NeoGraft 2.0 for hair restoration.

symplr, a leading healthcare governance, risk and compliance (“GRC”) software-as-a-service (“SaaS”) platform, backed by Clearlake Capital Group, L.P. (together with its affiliates, “Clearlake”) and SkyKnight Capital (together with its affiliates, “SkyKnight”), today announced that it has acquired The Patient Safety Company (“TPSC”) from Main Capital Partners (“Main”). Financial terms were not disclosed.

Tandem Diabetes Care, Inc., a leading insulin delivery and diabetes technology company, announced that management will be attending the following upcoming investor conferences

SPI Research recognizes Guidewire’s Professional Services team as a top performer in its annual Professional Services Maturity™ Benchmark

Predictive Technology Group (OTC PINK: PRED) (“Predictive” or “The Company”), a leader in helping identify barriers that impact women’s health and build healthier families through its innovations to deliver personalized medicine, today announced financial results for the fiscal second quarter ended December 31, 2019 and provided a corporate update.

The global dental membrane and bone graft substitutes market was valued at ~US$ 620 mn in 2018, and is projected to expand at a high CAGR from 2019 to 2027.